ARCHIVES

NCI Advisors Approve New $5 Million Program For Reagent Contracts.

This article is from The Cancer Letter archive.

Vol. 35 No. 27 | July 10, 2009

Download PDF Visit The Full Archive

Related Articles

Hopkins Begins Review Of All Studies After OHRP Lifts Research Suspension.

July 27, 2001

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

February 25, 2011

Avastin Improves Survival By 30 Percent In Advanced Non-Small Cell Lung Cancer

June 24, 2005

NCI-Approved Clinical Trials Listed For January

January 28, 2005

NCI Objections Delay GAO Report On Cancer Control

March 7, 1980

In Brief: Cancer Bill Nearly Became Law Without Nixon’s Signature as Impeachment Obsesses White House

August 2, 1974